MACLEODS PHARMA USA Trademark

Trademark Overview

On Thursday, May 10, 2012, a trademark application was filed for MACLEODS PHARMA USA with the United States Patent and Trademark Office. The USPTO has given the MACLEODS PHARMA USA trademark a serial number of 85621516. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, November 13, 2020. This trademark is owned by Macleods Pharmaceuticals Ltd.. The MACLEODS PHARMA USA trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, blood, psychiatric and immune system related diseases and disorders; antibiotic preparations; pharmaceutical anti-allergic preparations; pharmaceutical preparations for the treatment of pain; all of the foregoing goods for human use
macleods pharma usa

General Information

Serial Number85621516
Word MarkMACLEODS PHARMA USA
Filing DateThursday, May 10, 2012
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, November 13, 2020
Registration Number4605956
Registration DateTuesday, September 16, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 3, 2013

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, blood, psychiatric and immune system related diseases and disorders; antibiotic preparations; pharmaceutical anti-allergic preparations; pharmaceutical preparations for the treatment of pain; all of the foregoing goods for human use
Disclaimer with Predetermined Text"PHARMA USA"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 16, 2012
Primary Code005
First Use Anywhere DateSaturday, June 21, 2014
First Use In Commerce DateSaturday, June 21, 2014

Trademark Owner History

Party NameMacleods Pharmaceuticals Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressMumbai 400059
IN
Party NameMacleods Pharmaceuticals Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressMumbai 400059
IN
Party NameMacleods Pharmaceuticals Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressMumbai 400059
IN

Trademark Events

Event DateEvent Description
Saturday, September 16, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, November 13, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, November 13, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, November 10, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, September 18, 2020TEAS SECTION 8 & 15 RECEIVED
Monday, September 16, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, September 16, 2014REGISTERED-PRINCIPAL REGISTER
Thursday, August 14, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, August 13, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, August 12, 2014STATEMENT OF USE PROCESSING COMPLETE
Tuesday, July 15, 2014USE AMENDMENT FILED
Monday, August 4, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 15, 2014TEAS STATEMENT OF USE RECEIVED
Monday, July 14, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 28, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 3, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 3, 2013PUBLISHED FOR OPPOSITION
Wednesday, November 13, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 30, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, October 29, 2013EXPARTE APPEAL TERMINATED
Tuesday, October 29, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 24, 2013ASSIGNED TO LIE
Tuesday, October 22, 2013TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, October 22, 2013EX PARTE APPEAL-INSTITUTED
Tuesday, October 22, 2013JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, October 22, 2013EXPARTE APPEAL RECEIVED AT TTAB
Wednesday, April 24, 2013NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, April 24, 2013FINAL REFUSAL E-MAILED
Wednesday, April 24, 2013FINAL REFUSAL WRITTEN
Friday, March 29, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 28, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 28, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, March 23, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, March 23, 2013NON-FINAL ACTION E-MAILED
Saturday, March 23, 2013NON-FINAL ACTION WRITTEN
Friday, March 1, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 1, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 1, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, September 1, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, September 1, 2012NON-FINAL ACTION E-MAILED
Saturday, September 1, 2012NON-FINAL ACTION WRITTEN
Saturday, September 1, 2012ASSIGNED TO EXAMINER
Wednesday, May 16, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 14, 2012NEW APPLICATION ENTERED

Related Keywords

pharma macleods preparations pharmaceutical treatment related diseases system psychiatric blood disorders immune